Neuboron (China)

Neuboron (China) is a company headquartered in Nanjing, China. It is associated with boron neutron capture therapy (BNCT), an advanced form of targeted radiotherapy that combines a boron-containing drug with neutron irradiation to destroy cancer cells while sparing surrounding healthy tissue. The company is part of the broader Neuboron group of companies, which has pursued the development and commercialization of BNCT systems and related technologies. Neuboron (China) appears in public company registries and knowledge bases as a Nanjing-based enterprise. Its official website presents the company in English and Chinese, indicating an intent to serve both domestic and international audiences. The company operates in the medical technology and life sciences sector, with a focus on accelerator-based BNCT systems and related clinical infrastructure. Because the available evidence is limited to its identity as a company in Nanjing, China, this dossier does not assert specific founding dates, ownership structures, funding rounds, or product model names. The company should be understood as a China-based corporate entity in the BNCT and advanced radiotherapy space, with its headquarters in Nanjing and an online presence at neuboron.com.

Neuboron (China) is documented in public knowledge bases as a company located in Nanjing, China. The available evidence does not provide a detailed corporate history, founding date, or list of historical milestones. The company is associated with the Neuboron name, which is linked to the development of boron neutron capture therapy (BNCT) technology. BNCT is a binary cancer treatment approach that requires both a boron-10-containing compound that preferentially accumulates in tumor cells and a neutron beam to trigger a localized cellular reaction. The Neuboron group has been involved in building accelerator-based BNCT systems intended for clinical use. As a Nanjing-based entity, Neuboron (China) likely serves as a Chinese operating or development arm within the broader Neuboron organization. Its official website, available in English and Chinese, suggests engagement with both domestic Chinese and international markets. However, without further sourced evidence, specific events such as incorporation dates, partnerships, clinical trial authorizations, or product launches cannot be confirmed here. The company remains active as of the available records.

China-based medical technology company focused on boron neutron capture therapy (BNCT).

Product categories. Boron neutron capture therapy (BNCT) systems · Accelerator-based neutron sources · BNCT-related medical technology

1. 1Neuboron (China) - Wikidatawikidata.org
2. 2Neuboron official websiteneuboron.com